| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0005 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0005 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |